Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
730.80
442.93
399.36
611.09
744.86
658.41
467.17
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
730.80
442.93
399.36
611.09
744.86
658.41
467.17
Raw Material Cost
119.36
408.84
169.22
163.40
147.54
142.76
101.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
36.41
41.00
24.44
58.86
64.62
66.01
57.30
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
21.71
20.84
7.57
5.23
4.50
4.47
4.92
Selling and Distribution Expenses
99.05
124.69
74.12
127.72
124.25
161.38
125.66
Other Expenses
9.58
25.77
18.69
14.03
70.43
12.21
15.56
Total Expenditure (Excl Depreciation)
372.37
853.02
462.24
495.51
1,045.24
496.73
444.98
Operating Profit (PBDIT) excl Other Income
358.40000000000003
-410.09999999999997
-62.9
115.60000000000001
-300.4
161.70000000000002
22.200000000000003
Other Income
8.17
22.75
7.68
6.57
12.10
13.81
15.19
Operating Profit (PBDIT)
380.30
-374.58
-33.38
137.01
-274.38
189.82
51.52
Interest
21.71
20.84
7.57
5.23
4.50
4.47
4.92
Exceptional Items
-1.71
0.50
-131.28
36.72
-90.73
0.73
1.53
Gross Profit (PBDT)
611.44
34.10
230.13
447.69
597.31
515.65
365.68
Depreciation
13.70
12.75
21.82
14.86
13.91
14.33
14.13
Profit Before Tax
343.17
-407.68
-194.05
153.64
-383.52
171.74
34.01
Tax
12.21
4.55
-14.10
-43.25
63.99
12.69
0.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
330.96
-412.23
-179.95
196.89
-447.51
159.05
33.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
330.96
-412.23
-179.95
196.89
-447.51
159.05
33.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
330.96
-412.23
-179.95
196.89
-447.51
159.05
33.61
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,505.10
1,140.62
1,320.12
1,357.38
1,142.72
1,527.74
1,221.07
Earnings per share (EPS)
2.88
-3.93
-1.8
1.89
-4.6
1.61
0.34
Diluted Earnings per share
2.88
-3.93
-1.8
1.89
-4.6
1.61
0.34
Operating Profit Margin (Excl OI)
49.05%
-92.58%
-15.75%
18.91%
-40.33%
24.56%
4.75%
Gross Profit Margin
48.83%
-89.16%
-43.13%
27.57%
-49.62%
28.26%
10.3%
PAT Margin
45.29%
-93.07%
-45.06%
32.22%
-60.08%
24.16%
7.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -1.89% vs 80.15% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 173.97% vs -1,339.61% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 229.88% vs -701.89% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 382.22% vs 7.14% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Sarepta Therapeutics, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(USD)
Change(%)
Net Sales
730.80
630.58
100.22
15.89%
Other Operating Income
0.00
0.00
0.00
Total Operating income
730.80
630.58
100.22
15.89%
Raw Material Cost
119.36
1.17
118.19
10,101.71%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
36.41
0.00
36.41
Power Cost
0
0
0.00
Manufacturing Expenses
21.71
93.72
-72.01
-76.84%
Selling and Distribution Expenses
99.05
158.32
-59.27
-37.44%
Other Expenses
9.58
-5.39
14.97
277.74%
Total Expenditure (Excl Depreciation)
372.37
199.28
173.09
86.86%
Operating Profit (PBDIT) excl Other Income
358.43
431.30
-72.87
-16.90%
Other Income
8.17
25.79
-17.62
-68.32%
Operating Profit (PBDIT)
380.30
659.44
-279.14
-42.33%
Interest
21.71
93.72
-72.01
-76.84%
Exceptional Items
-1.71
-96.29
94.58
98.22%
Gross Profit (PBDT)
611.44
629.40
-17.96
-2.85%
Depreciation
13.70
1.17
12.53
1,070.94%
Profit Before Tax
343.17
468.26
-125.09
-26.71%
Tax
12.21
0.00
12.21
Provisions and contingencies
0
0
0.00
Profit After Tax
330.96
294.69
36.27
12.31%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
330.96
294.69
36.27
12.31%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
173.57
-173.57
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
330.96
468.26
-137.30
-29.32%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,505.10
6,888.55
-5,383.45
-78.15%
Earnings per share (EPS)
2.88
0.67
2.21
329.85%
Diluted Earnings per share
2.88
0.67
2.21
329.85%
Operating Profit Margin (Excl OI)
49.05%
100.30%
0.00
-51.25%
Gross Profit Margin
48.83%
74.44%
0.00
-25.61%
PAT Margin
45.29%
46.73%
0.00
-1.44%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 73.08 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 65.00% vs 10.89% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -1.89% vs 80.15% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 33.10 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 180.30% vs -129.13% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 173.97% vs -1,339.61% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.21 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 193.66% vs -866.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 229.88% vs -701.89% in Mar 2025
Quarterly - Interest
Interest 2.17 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 4.33% vs 173.68% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 382.22% vs 7.14% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 49.05%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
